Article Text

AB0797 Impairment of coronary microcirculation in patients with diffuse systemic sclerosis
  1. F. Atzeni1,
  2. L. Gianturco2,
  3. P. Sarzi-Puttini1,
  4. C. Ricci3,
  5. L. Tommasoni2,
  6. V. De Gennaro Colonna4,
  7. P. Ferrario4,
  8. O. Epis5,
  9. M. Turiel2
  1. 1Rheumatology Unit, L.Sacco University Hospital of Milan
  2. 2Department of Health Technologies, Cardiology Unit, IRCCS Galeazzi Orthopedic Institute, University of Milan
  3. 3GAM Institute of Medical Statistics and Biometry, Faculty of Medicine, University of Milan, Clinical Epidemiology and Biometry Unit, IRCSS Policlinico San Donato, Milan, Milan
  4. 4Pharmacology Department, University of Milan, Milan
  5. 5Rheumatology Unit, Ca’ Granda Niguarda Hospital, Milan, Italy


Background An association between systemic autoimmune diseases (SADs) and atherosclerosis has been described in many connective tissue diseases, and is known to lead to increased cardiovascular (CV) morbidity and mortality. Systemic sclerosis (SSc) ischaracterised by multi-system organ inflammation, endothelial wall damage and vasculopathy (1). There are many markers of endothelial dysfunction and/or atherosclerotic risk, such as asymmetric dimethylarginine (ADMA), arterial stiffness parameters, carotid intima-media thickness (cIMT) and coronary flow reserve (CFR) assessed by means of trans-thoracic echocardiography (TTE).

Objectives The aim of this pilot study was to use various endothelial and atherosclerosis markers to identify early CV involvement in a group of SSc patients.

Methods The study involved 20 patients (two males, 18 females; mean age 52.96±12.51 years) with diffuse SSc but no signs or symptoms of CV disease (CVD), and 20 age- and gender-matched controls. All underwent a dipyridamole echocardiographic stress test which included a determination of CFR, and an evaluation of cIMT, arterial stiffness and plasma ADMA levels.

Results All the arterial wall measurements of the diffuse SSc group were significantly different from those of controls and both right and left cIMT, pulse wave velocity (PWV), and stiffness index β were also all significantly elevated in SSc patients compared to healthy controls (Table 1). Moreover, in patients with diffuse SSc CFR was significantly lower (P=0.0033) and plasma ADMA levels higher (P<0.0001) than in healthy controls (Table 1).

Table 1. Cardiovascular parameters in the SSc patients and healthy controls

Conclusions This study showed that those SSc patients without any clinical evidence of CVD had subclinical atherosclerosis, which was suggested by early impairment of coronary microcirculation and macrovascular involvement.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.